l carnitine increase estrogen androgen receptors L-carnitine improves polycystic ovary syndrome by increasing CYP11A1, receptor, and decreasing XNIP Frontiers | Age and APOE

MDM2, murine double minute-2

This study reports the results of a large, multi-centre, randomized, placebo-controlled clinical trial, which demonstrated a 20% reduction in lung cancer mortality from the use of chest CT screening

Yang X, Yang C, Zhang S, Geng H, Zhu AX, Bernards R, et al

FDA-approved options like semaglutide (Wegovy) and tirzepatide (Zepbound) have decades of clinical outcome data behind them

BPC-157 is a research compound not approved by the FDA for human use

Therefore, consistent with the burden estimates for this measure under OMB control number 0938-1270, we estimate the removal of this measure will decrease burden for voluntary reporting for the CY 2025 reporting period by 383 hours (4,590 ASCs 50 percent of ASCs 0.167 hours per ASC) at a savings of $21,088 (383 hours $55.06/hour) and 765 hours annually (0.167 hours 4,590 ASCs) at a savings of $42,121 (765 hours $55.06/hour) for mandatory reporting beginning with the CY 2026 reporting period